Researcher Background
Primary Academic Title
Professor, Biomedical Engineering, WashU Medicine
Training
- 2014: Sabbatical, Sofinnova Ventures, Menlo Park, CA
Education
- 1998: BS, Iowa State University, Ames, IA
- 2001: MS, Univeristy of Illinois, Urbana, IL
- 2003: PhD, University of Illinois, Urbana, IL
Research & Selected Publications
Research Interest
Cory Berkland’s lab studies pharmaceuticals and biomaterials with a particular emphasis on molecular design, drug formulation, and transport in the human body. Professor Berkland is a co-founder of Orbis Biosciences (acquired by Adare Pharmaceuticals), Savara Pharmaceuticals (NASDAQ:SVRA), Bond Biosciences, and several other start-ups. Professor Berkland is currently CSO of Bond Biosciences and is an executive and chairman of the board for Kinimmune and Axioforce.
Research Publications